转移性或复发性低度子宫内膜癌的治疗模式不断变化:什么时候使用激素治疗是首选选择?
Haider Mahdi1,2, Isabelle Ray-Coquard3, Domenica Lorusso4,5
1Department of Obstetrics and Gynecology, Women's Health Institute, Cleveland Clinic, Cleveland, Ohio, USA.
概括
分子分类推进了对复发性或转移性疾病的子宫内膜癌治疗. 整合分子和临床病理学数据可以改善低度子宫内膜腺癌的治疗选择和研究设计.
科学领域:
- 妇科瘤学 妇科瘤学
- 分子病理学分子病理学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 子宫内膜癌是一种常见的恶性瘤,发病率和死亡率不断增加.
- 目前用于转移或复发性子宫内膜癌的治疗方法具有显著的毒性.
- 不同质的瘤分类使治疗决策和临床试验解释变得复杂.
研究的目的:
- 讨论转移性或复发性低度子宫内膜腺癌的治疗方法.
- 突出分子分类在指导治疗决策中的重要性.
- 强调分子和临床病理学数据的整合,以改善患者的治疗结果.
主要方法:
- 关于治疗子宫内膜癌的当前文献的综述.
- 对分子分类进步的分析.
- 讨论治疗策略的临床病理整合.
主要成果:
- 分子分类为转移性或复发性子宫内膜癌提供了更好的指导.
- 分子和临床病理特征的整合可以优化治疗选择.
- 低度子宫内膜腺癌具有独特的特征,需要量身定制的方法.
结论:
- 分子洞察对于完善子宫内膜癌的治疗策略至关重要.
- 以分子数据为指导的个性化医疗方法对于管理复发性或转移性疾病至关重要.
- 结合分子和临床病理学数据的进一步研究将提高治疗疗效和临床试验设计.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Hormonal Regulation of the Menstrual Cycle
435
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
435
Hormonal Control of the Ovarian Cycle
565
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
565
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Disorders of the Female Reproductive System
405
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
405
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K


